ABSTRACT Information on the stage of liver fibrosis is essential for decisions on antiviral treatment for chronic hepatitis B virus (HBV). This paper aims to establish a non-invasive assessment model with serum markers using cloud computing and the Internet of Things for the evaluation of liver disease severity and its prognosis. Based on the Internet of Things, the multiple and key information system of liver fibrosis or cirrhosis are constructed using the serum markers data. In the cloud platform, the probability density functions of indexes are used to select the optimized indicators. The logistic regression is used to establish the non-invasive assessment model. The patients were selected with CHB and underwent liver biopsy in the Second Xiangya Hospital, Central South University. There are two inclusion criteria: first, the patient received a liver biopsy according to ''Proclaim Prevention and Cure Guide For Chronic Hepatitis B'' of Chinese Medical Association in 2015; second, the patient has a history of hepatitis B or HBV surface antigen (HBsAg) positive more than six months, and HBsAg and (or) HBV DNA is still positive. Results of clinical data applications show that the accuracy of the non-invasive assessment model reaches greater than 70% for the recognition of significant liver fibrosis. In addition, the discriminant accuracy can be improved by increasing the number of indicators. The established non-invasive assessment model can be used for auxiliary clinical diagnosis after the further validation.
I. INTRODUCTION
Chronic hepatitis B virus (HBV) infection affects an estimated 257 million individuals worldwide and about one million people chronically infected with HBV die from chronic liver diseases(including cirrhosis and hepatocellular carcinoma) in 2015 [1] . Many experimental and clinical literature data published in the last decade have indicated that liver fibrosis even earlier cirrhosis may be reversible [2] - [4] . Therefore, it is essential for the prognostication and decisions on antiviral treatment to identify the stage of liver fibrosis. Liver biopsy remains the gold standard for assessing the stages of liver fibrosis. Although liver biopsy is a safe procedure, it also has several disadvantages such as sampling error, poor patient compliance, the risk of poorly standardized collection of the liver tissues, limited usefulness for dynamic surveillance and follow-up, as well as poor observation concordance [5] - [9] . With all these limitations, accurate and reliable non-invasive predictors of histology are desperately needed to assess the hepatic fibrosis. Many studies have been performed using the readily available laboratory test results to predict significant fibrosis or cirrhosis [10] - [16] .
Fibroscan is a non-invasive, painless, rapid (<5 min), and reproducible method for measuring liver stiffness with no complications. It cannot only be used for non-invasive diagnosis of liver fibrosis and monitoring the progress of liver disease, but also evaluating the effects of antiviral therapy or anti-fibrosis treatment. However, in overweight and obese patients (BMI>28), Fibroscan is unable to obtain results because the fatty thoracic belt attenuates both elastic waves and ultrasound. In addition, the large blood vessels in the liver will likely to lead to the incorrect results, so the great vessels structure needs to be avoided at diagnosis. Ascites is a physical limitation to the Fibroscan application [17] . For the hepatitis patients with acute liver damage, Fibroscan will overestimate the real stage of liver fibrosis [18] . Cholestasis and total bilirubin increased liver stiffness measurement value [19] .
The non-invasive predictors of histology for discriminating significant fibrosis or cirrhosis were summarized in Table 1 . Through statistical analysis, these comprehensive serum models were established using one or more specific indexes. The common characteristic is that the AUC is greater than 0.7, and its detection is obtained from clinical practice, which performs well in the diagnostic aspects of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. However, the unified comprehensive model for evaluating the degrees of fibrosis and inflammatory activity is scarce currently.
Therefore, it is very important to develop a comprehensive model considering multiple serum indicators, which characterized by safety rapidity and repeatability. This model is expected to dynamically evaluate and monitor the progress of chronic liver fibrosis, and especially it can provide an alternative to the liver biopsy in the follow-up visit.
In recent years, the internet of things [20] , [21] and cloud computing [22] - [24] technologies provide a good technical guarantee for the achievement of this goal. In view of this, in this paper, a non-invasive testing system with serum makers using cloud computing and internet of things were established. The multiple information is used to evaluate the liver disease severity and its prognosis. In the data collect layer, the serum markers such as the blood routine indexes are collected and uploaded through the internet of things. In the cloud computing layer, the probability density functions are applied to select the optimized indicators, and the logistic regression is used to establish the non-invasive assessment model. In the non-invasive assessment layer, it is feasible to carry out the model optimization, evaluation of liver disease severity, and prognosis.
II. HIERARCHICAL STRUCTURE OF NON-INVASIVE ASSESSMENT SYSTEM USING CLOUD COMPUTING AND INTERNET OF THINGS FOR LIVER DISEASE SEVERITY
The hierarchical structure of the non-invasive assessment system is shown in Figure I , which composes of three layers: the data collect layer, the cloud computing layer, and the noninvasive assessment layer.
A. DATA COLLECT LAYER
This study was approved by the Clinical Research Committee of Second Xiangya Hospital, Central South University. Chronic HBV infection was diagnosed according to the guidelines published by the American Association for the Study of Liver Diseases in 2009 [25] and the latest ''Proclaim Prevention and Cure Guide for Chronic Hepatitis B'' from Chinese Medical Association in 2015 [26] . Cases with chronic HBV infection were included in this study if positive hepatitis B surface antigen (HBsAg) had been detected in the serum for at least 6 months or liver biopsies were evaluated by three senior pathologists in the Laboratory of Pathology, Second Xiangya Hospital. Cases were excluded from the study if biopsy evaluation showed no fibrosis. Patients diagnosed with chronic HBV infection but coinfected with HIV, hepatitis C virus, or hepatitis D virus were excluded from the study. The chronic HBV infected patients with the following diseases meanwhile were also excluded from this study, which are the nonalcoholic steatohepatitis, autoimmune liver diseases including autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis, as well as hereditary and metabolic liver diseases such as Wilson's disease, FIGURE 1. The hierarchical structure of the non-invasive assessment system.Through the combination of data collect layer, cloud computing layer, and non-invasive layer, the liver disease severity and its prognosis can be evaluated and prognosticated.
hemochromatosis, and α-1-antitrypsin deficiency. Patients with chronic HBV infection due to long-term exposure to toxic drugs and industrial toxicants, liver microcirculatory dysfunction, HCC, liver transplantation, and schistosomiasis need to be excluded from the study. Therefore, 1246 cases with chronic HBV infection were retrospectively recruited from March 2005 to December 2010 in the Department of Infectious Diseases, Second Xiangya Hospital. The serum markers of these cases can be collected and uploaded in the internet of things.
B. CLOUD COMPUTING LAYER
The cloud computing layer includes the selection of the optimized indicators and the establishment of non-invasive assessment model, which is the third layer of the non-invasive testing system. With the data transmitted from the internet of things, the important parameters including the key indicators and parameters of model can be solved through the cloud computing platform. Besides, these calculation results are also stored in this cloud computing platform, which means that the results can be downloaded from the platform whenever necessary. Therefore, a great convenience and sufficient data will be provided for decisions on antiviral treatment for chronic HBV.
C. NON-INVASIVE ASSESSMENT LAYER
The top layer of non-invasive assessment system is the test and application layer, which includes the model optimization, evaluation of liver disease severity, and prognosis. In this work, the output results of the liver disease severity from the cloud computing platform can be divided into two levels, which are the level 1 and the level 2. The level SL1 represents the degree of liver fibrosis as no significant liver fibrosis which was determined with S1 to S2. The level SL2 represents significant liver fibrosis with S3 to S4. The inflammation necrosis of G1 and G2 were classified as less severity GL1, and from G3 to G4 were classified as severity GL2.
III. NON-INVASIVE ASSESSMENT AND DISCUSSION

A. INDICATORS
The serum indicators are listed below, which are Hemoglobin(Hb), Red Blood Cells(RBC), White Blood Cells (WBC), Neutrophils(Neu), Platelets(PLT), Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Albumin (ALB), Globulin (GLO), Total Bilirubin (TBIL), Direct Bilirubin(DBIL), Total Bile Acid(TBA), prothrombin time activity percentage(PTA), international normalized ratio(INR), HBsAg, HBsAb, HBeAg, HBeAb, HBcIgG, HBcIgM, and HBV-DNA.
All cases underwent liver biopsy after the admission were guided by the ultrasound. The length of the liver tissue specimen is not less than 1 cm, which contains at least 6 portal areas. The liver tissue will be processed successively by formaldehyde fixation, paraffin embedding, sectioning, conventional HE staining, and mesh dyeing. The fibrosis score of portal tract was graded by Knodell scoring system (Inflammatory necrosis grade from G1 to G4, degree of fibrosis stages from S1 to S4). Three pathology experts identify all the pathological images.
The correlation of multiple diagnostic indexes and the degree of fibrosis (S), as well as the correlation of multiple diagnostic indexes and the degree of inflammatory activity (G) were analyzed using ROC characteristic.
Based on the analyses of ROC characteristic curves, results show that the areas under ROC curves of 23 indicators, There are 12 indicators including Sex, Age, ALT, AST, GLO, TBIL, DBIL, TBA, PTA, INR, HBsAb, and HBeAb, where the areas for both the inflammation degree and significant liver fibrosis are greater than 0.5. The highest sensitivity index is GLO. The probability density functions of GLO for the identification of significant liver fibrosis were shown in Figure 2 . It shows the probability density distributions of GLO for SL1 and SL2 are also different, where the peak values focus at 26 and 35, respectively.
B. NON-INVASIVE ASSESSMENT OF LIVER DISEASE SEVERITY BASED ON LOGISTIC REGRESSION IN CLOUD COMPUTING LAYER
The optimized indicators were selected as discriminant indexes and then the models were established using logistic regression. Logistic regression measures the relationship between a categorical dependent variable and one or more independent variables, which are usually (but not necessarily) continuous, using probability scores as the predicted values of the dependent variable. It is a statistical modeling technique in which the probability of a category is related to a set of explanatory variables. An explanation of logistic regression begins with a detailing of the logistic function, which always takes on values between zero and one. The logistic classification model is defined by the following equations:
Where Y is a measure of the contribution for the variables X i (i = 1, .., 6). C i are the regression coefficients that are usually estimated using maximum likelihood estimation [27] - [29] . Unlike linear regression with normally distributed residuals, it is not possible to find a closed-form expression for the coefficient values that maximizes the likelihood function, so an iterative process must be used instead. P (Y ) is the categorical response of variables that represents the probability of a particular outcome. In present application, C 1 , C 2 , C 3 , . . . , C n are the coefficients of indicators including Sex, Age, Hb, RBC, WBC, Neu, PLT, ALT, AST, ALB, GLO, TBIL, DBIL, TBA, PTA, INR, HBsAg, HBsAb, HBeAg, HBeAb, HBcIgG, HBcIgM, and DNA. P(Y ) is the probability of a data point that tagged as a GL2/GL1/SL1/SL2. The threshold is 0.5, the record is regarded as a GL2/SL2 when P(Y ) > 0.5, otherwise it is regarded as a GL1/SL1. The discriminant function of logistic regression using the 12 selected indexes, including Sex, Age, ALT, AST, GLO, TBIL, DBIL, TBA, PTA, INR, HBsAb, and HBeAb, are listed in Table 2 B is the coefficient of the index. S.E. indicates the standard error around the coefficient for the constant. Wald and Sig. indicate the Wald chi-square test that tests the null hypothesis that the constant equals 0. This hypothesis is rejected because the p-value (listed in the column called ''Sig.'') is smaller than the critical p-value of 0.05 (or 0.01). Hence, we conclude that the constant is not 0. Exp(B) indicates the exponentiation of the B coefficient, which is an odds ratio. This value is given by default because odds ratios can be easier to interpret than the coefficient, which is in logodds units. Through the established model, the classification results contain 565 GL1 and 310 GL2 samples. The correct classification accuracies are 81.2% and 56.7% for GL1 and GL2, respectively. The overall accuracy is 70.4%.
The discriminant functions of logistic regression using 23 indexes are listed in Table 3 . A total of 552 GL1 and 344 GL2 samples are predicted using the classification model. The corresponding classification accuracies are 79.9% and 64.2%, respectively. The overall percentage is 73%. Althoughthe accuracy for GL1 decreases, the accuracy for GL2 and overall classification accuracy increase.
C. RESULTS AND DISCUSSIONS
Clearly, it can be seen that the overall classification accuracy of the logistic regression model with 23 indexes is higher than that with 12 selected indexes, which indicates that the accuracy can be improved by multiple indexes. The probability density functions were used to investigate the different characteristics of indicators for the degree of fibrosis (S) and the degree of inflammatory activity (G). The areas under ROC curves of PLT are 0.29 for the degree of inflammatory activity (G) and 0.284 for the degree of fibrosis (S), which is the minimum value in 23 indexes for both the degree of fibrosis and inflammatory activity. It indicates that PLT owns the least sensitivity for the degrees of fibrosis and inflammatory activity. The probability density functions of PLT for the inflammation degree were shown in Figure 3 . It is clearly that the probability density distributions of PLT for GL1 and GL2 are different, and the peak values focus at 175 and 100, respectively. Thus, it can be indicated that PLT has different characteristics for GL1 and GL2. To compare the influence of PLT on discriminant accuracy, the parameters of logistic regression discriminant function using 12 selected indexes and PLT are calculated, which are listed in Table 4 . Through the classification of 556 GL1 and 339 GL2 samples, the classification accuracies are 79.9% and 62% for GL1 and GL2, respectively. The overall classification accuracy is 72%. The results show that the overall accuracy is improved from 70.4% to 72%.
Since the probability densities may be different from the areas under the ROC curves. With very similar probability densities and smaller areas under the ROC curves, Hb and RBC were included in the models to investigate the accuracy change. The probability density functions of Hb and RBC for the inflammation degree were shown in Figures 4 and 5 , respectively. The logistic regression discriminant function using selected 12 indexes, PLT, Hb, and RBC are calculated and listed in Table5.
Through the classification of 561 GL1 and 345 GL2 samples, the classification accuracies are 80.6% and 63.1% for GL1 and GL2, respectively. The overall accuracy is 72.9%. Obviously, the accuracies for GL1and GL2, as well as the overall accuracy increase, and the overall accuracy is improved from 70.4% to 72.9%. It means that the indicators Hb and RBC can also improve the discriminant accuracy, though they have very similar probability density distributions and smaller areas under the ROC curves between GL1 and GL2.
With very different probability density distributions between GL1 and GL2, as well as a smaller area under the ROC curve, ALB was included in the models to investigate the accuracy change. Figure 6 shows the probability density functions of ALB for the degree of fibrosis.
The logistic regression discriminant function of using 12 selected indexes, PLT, Hb, RBC, and ALB are calculated VOLUME 6, 2018 and listed in Table 6 . Using the samples of 560 GL1 and 348 GL2, the classification accuracies are 80.5% and 63.6% for GL1 and GL2, respectively. The overall accuracy is 73%. It shows the classification accuracy for GL1 decreases slightly, but the accuracy for GL2 and overall accuracy increase, where the overall percentage is improved from 70.4% to 73%. It can be clearly concluded that the overall discriminant accuracy can be improved by increasing the number of indicators. 
IV. CONCLUSIONS
A non-invasive assessment model of liver disease severity by serum markers using cloud computing and internet of things were established in this paper. It includes three layers: data collect layer, cloud computing layer, and non-invasive assessment layer. The correlation of multiple diagnostic indexes and the degree of fibrosis (S), as well as the correlation of multiple diagnostic indexes and the degree of inflammatory activity (G) were analyzed using ROC characteristic. 23 indicators including Sex, Age, Hb, RBC, WBC, Neu, PLT, ALT, AST, ALB, GLO, TBIL, DBIL, TBA, PTA, INR, HBsAg, HBsAb, HBeAg, HBeAb, HBcIgG, HBcIgM, and DNA are analyzed. The 12 indicators including Sex, Age, ALT, AST, GLO, TBIL, DBIL, TBA, PTA, INR, HBsAb, and HBeAb, where the areas for both the inflammation degree and significant liver fibrosis are greater than 0.5.The highest sensitivity index is GLO. Through the classification of 565 GL1 and 310 GL2 samples with the 12selected indicators,the classification accuracies are 81.2% and 56.7 for GL1 and GL2, respectively. The overall accuracy is 70.4%. Through the classification of 552 GL1 and 344 GL2 samples using 23 indexes, the classification accuracies are 79.9% and 64.2% for GL1 and GL2, respectively. Compared to that of the model with 12 indicators,the accuracy for GL1 decreases, but the accuracies for GL2 and the overall accuracy increase. Results from the probability density distributions and the areas under the ROC curves may be different. However, even the probability density functions of Hb and RBC are very similar between GL1 and GL2, they still can improve the discriminant accuracy. It also concludes that PLT has the least sensitivity for the degrees of fibrosis and inflammatory activity, but the classification results show that it can improve the overall accuracy from 70.4% to 72%. Through the data analysis and practical application, it is proved that the developed non-invasive assessment model of liver disease severity by serum markers using cloud computing and internet of things can not only achieve efficient classification for GL1 and GL2, as well as SL1 and SL2, but also calculate the G/S levels using the advantages of multiple indicators, which is a novel idea and an effective evaluation method for decisions on antiviral treatment for chronic HBV. 
